Facilitator | Janet Dancey, MD, FRCP(C) Dr. Dancey is an international leader in cancer clinical trials of experimental therapeutics and has special expertise in new anti-cancer drug development. Her research interests involve linking drug and biomarker development, and associated clinical trials methodology, including development of novel trials for patients with rare tumours. As Chair, she has advanced CCTG’s research strategy and expanded its portfolio dramatically. A prolific author with an excellent citation record, she is a sought-after speaker, both nationally and internationallyNovember 6, 2 – 3:30 pm ET | Virtual Introduction to CCTG structure and organizationTerms of Reference for Disease Site and Executive CommitteesMentoring/ Capacity Building for Next Generation of LeadersMembership and career development opportunities through CCTGOpen forum – VISION program experienceExit interviews/feedback survey (confidential)
